Lymph node positive head and neck carcinoma after curative radiochemotherapy: A long lasting debate on elective post-therapeutic neck dissections comes to a conclusion

Cancer/Radiotherapie

Volumn 17, Issue 4, 2013, Pages 323-331

  Hermann, R M ^a,b   Christiansen, H ^a   Rodel R M ^c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Zentrum für Strahlentherapie und Radioonkologie Westerstede Bremen   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Head and neck squamous cell carcinoma; Neck dissection; Radiochemotherapy; Tumor response

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL;

BRACHYTHERAPY; CANCER CONTROL; CANCER RECURRENCE; CANCER REGRESSION; CANCER SIZE; CERVICAL LYMPH NODE; CHEMORADIOTHERAPY; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DELAYED DIAGNOSIS; DISTANT METASTASIS; ELECTIVE SURGERY; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; INDUCTION CHEMOTHERAPY; LYMPH NODE; LYMPH NODE METASTASIS; MICROMETASTASIS; MINIMAL RESIDUAL DISEASE; MULTICENTER STUDY (TOPIC); NECK DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT RESPONSE;

CARCINOME ÉPIDERMOÏDE DES VOIES AÉRODIGESTIVES SUPÉRIEURES; CHIMIORADIOTHÉRAPIE; CURAGE GANGLIONNAIRE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; NECK DISSECTION; RADIOCHEMOTHERAPY; RÉPONSE PATHOLOGIQUE; TUMOR RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY; CISPLATIN; COMBINED MODALITY THERAPY; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MULTIMODAL IMAGING; NECK DISSECTION; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; PATIENT SELECTION; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURGICAL PROCEDURES, ELECTIVE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84880743465     PISSN: 12783218     EISSN: 17696658     Source Type: Journal    
DOI: 10.1016/j.canrad.2013.01.018     Document Type: Review

References (55)

1. Ferlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010, 127:2893-2917.
2. Simon C., Plinkert P.K. Multimodale Therapiestrategien bei der Behandlung von Kopf-Halskarzinomen. HNO 2008, 56:575-584.
3. Laskar S.G., Agarwal J.P., Srinivas C., Dinshaw K.A. Radiotherapeutic management of locally advanced head and neck cancer. Expert Rev Anticancer Ther 2006, 6:405-417.
4. Blanchard P., Baujat B., Holostenco V., Bourredjem A., Baey C., Bourhis J., et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site. Radiother Oncol 2011, 100:33-40.
5. Bourhis J., Lapeyre M., Tortochaux J., Lusinchi A., Etessami A., Ducourtieux M., et al. Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV locally advanced HNSCC: results of a GORTEC randomized trial. Radiother Oncol 2011, 100:56-61.
6. Lorch J.H., Goloubeva O., Haddad R.I., Cullen K., Sarlis N., Tishler R., et al. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial. Lancet Oncol 2011, 12:153-159.
7. Vermorken J.B., Remenar E., Herpen C., Gorlia T., Mesia R., Degardin M., et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 2007, 357:1695-1704.
8. Bonner J.A., Harari P.M., Giralt J., Azarnia N., Shin D.M., Cohen R.B., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006, 354:567-578.
9. Brizel D.M., Esclamado R. Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous cell carcinoma of the head and neck: consensus, controversy and conundrum. J Clin Oncol 2006, 24:2612-2617.
10. Leibel S.A., Scott C.B., Mohiuddin M., Marcial V.A., Coia L.R., Davis L.W., et al. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database. Int J Radiat Oncol Biol Phys 1991, 21:549-556.
11. Barkley H.T., Fletcher G.H., Jesse R.H., Lindberg R.D. Management of cervical lymph node metastases in squamous cell carcinoma of the tonsillar fossa, base of tongue, supraglottic larynx, and hypopharynx. Am J Surg 1972, 124:462-467.
12. Robbins K.T., Wong F.S.H., Kumar P., Hartsell W.F., Vieira F., Mullins B., et al. Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1999, 125:670-675.
13. Nouraei S.A.R., Upile T., Al-Yaghchi C., Lei M., Sandhu G.S., Stewart S., et al. Role of planned postcheomoradiotherapy selective neck dissection in the multimodality management of head and neck cancer. Laryngoscope 2008, 118:797-803.
14. Ferlito A., Robbins K.T., Shah J.P., Medina J.E., Silver C.E., Al-Tamini S., et al. Proposal for a rational classification of neck dissections. Head Neck 2011, 33:445-450.
15. Robbins K.T., Ashok R.S., Medina J.E., Califano J.A., Wolf G.T., Ferlito A., et al. Consensus statement on the classification and terminology of neck dissection. Arch Otolaryngol Head Neck Surg 2008, 134:536-538.
16. Puri A. Cervical neck dissection for complete responders in head-and-neck: a utilitarian ideal?. Int J Radiat Oncol Biol Phys 2012, 83:768.
17. Carinci F., Cassano L., Farina A., Pelucchi S., Calearo C., Modugno V., et al. Unresectable primary tumor of head and neck: does neck dissection combined with chemoradiotherapy improve survival. J Craniofac Surg 2001, 12:438-443.
18. Paximadis P.A., Christensen M.E., Dyson G., Kamdar D.P., Sukari A., Lin H.S., et al. Up-front neck dissection followed by concurrent chemoradiation in patients with regionally advanced head and neck cancer. Head Neck 2012, 34:1798-1803.
19. Hamoir M., Ferlito A., Schmitz S., Hanin F.X., Thariat J., Weynand B., et al. The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease. Oral Oncol 2012, 48:203-210.
20. Puri A. Need for neck dissection: a premature epitaph for obsolete paradigm. Int J Radiat Oncol Biol Phys 2012, 83:483-484.
21. Ferlito A., Corry J., Silver C.A., Shaha A.R., Robbins K.T., Rinaldo A. Planned neck dissection of patients with complete response to chemoradiotherapy: a concept approaching obsolence. Head Neck 2010, 32:253-261.
22. Thariat J., Hamoir M., Janot F., De Mones E., Marcy P.Y., Carrier P., et al. Neck dissection following chemoradiation for node positive head and neck carcinomas. Cancer Radiother 2009, 13:758-770.
23. Goguen L.A., Posner M.R., Tishler R.B., Wirth L.J., Norris C.M., Annino D.J., et al. Examining the need for neck dissection in the era of chemoradiation therapy for advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2006, 132:526-531.
24. Stenson K.M., Huo D., Blair E., Cohen E.E., Argiris A., Haraf D.J., et al. Planned post-chemoradiation neck dissection: significance of radiation dose. Laryngoscope 2006, 116:33-36.
25. Stenson K.M., Haraf D.J., Pelzer H., et al. The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. Arch Otolaryngol Head Neck Surg 2000, 126:950-956.
26. McHam S.A., Adelstein D.J., Rybicki L.A., Lavertu P., Esclamado R.M., Wood B.G., et al. Who merits a neck dissection after definitive chemoradiotherapy for N2-N3 squamous cell head and neck cancer. Head Neck 2003, 25:791-798.
27. Cannady S.B., Lee W.T., Scharpf J., Lorenz R.R., Wood B.G., Strome M., et al. Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma. Head Neck 2010, 32:348-356.
28. Argiris A., Stenson K.M., Brockstein B.E., Mittal B.B., Pelzer H., Kies M.S., et al. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer. Head Neck 2004, 26:447-455.
29. Brizel D.M., Prosnitz R.G., Hunter S., Fisher S.R., Clough R.L., Downey M.A., et al. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2004, 58:1418-1423.
30. Brizel D.M., Albers M.E., Fisher S.R., Scher R.L., Richtsmeier W.J., Hars V., et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998, 338:1798-1804.
31. Lavertu P., Adelstein D.J., Saxton J.P., Secic M., Wanamaker J.R., Eliachar I., et al. Management of the neck in a randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer. Head Neck 1997, 19:559-566.
32. Soltys S.G., Choi C.Y.H., Fee W.E., Pinto H.A., Le Q. A planned neck dissection is not necessary in all patients with N2-3 head-and-neck cancer after sequential chemoradiotherapy. Int J Radiat Oncol Biol Phys 2012, 83:994-999.
33. Vedrine P.O., Thariat J., Hitier M., Janot F., Kaminsky M.C., Makeieff M., et al. Need for neck dissection after radiochemotherapy. A study of the French GETTEC Group. Laryngoscope 2008, 118:1775-1780.
34. Thariat J., Ang K.K., Allen P.K., Ahamad A., Williams M.D., Myers J.N., et al. Prediction of neck dissection requirement after definitive radiotherapy for head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2012, 82:367-374.
35. Kwong D.L., Nicholls J., Wei W.I., Chua D.T., Sham J.S., Yuen P.W., et al. The time course of histologic remission after treatment of patients with nasopharyngeal carcinoma. Cancer 1999, 85:1446-1453.
36. Dooley L.M., Potts K.L., Wilson L.D., Cappello Z.J., Bumpous J.M. Treatment outcome in the residually positive neck after definitive chemotherapy and irradiation. Laryngoscope 2011, 121:1656-1661.
37. Zoephel K., Appold S., Abolmaali N. PET/CT based radiotherapy planning in patients with head and neck cancer. Nuklearmedizin 2008, 31:55-59.
38. Szmeja Z., Wierzbicka M., Kordylewska M. The value of ultrasound examination in preoperative neck assessment and in early diagnosis of nodal recurrences in the follow-up of patients operated for laryngeal cancer. Eur Arch Otorhinolaryngol 1999, 256:415-417.
39. Park J.J., Emmerling O., Westhofen M. Role of neck ultrasound during follow-up care of head and neck squamous cell carcinomas. Acta Otolaryngol 2012, 132:218-224.
40. Van der Putten L., van den Broek G.B., de Bree R., van den Brekel M.W.N., Balm A.J.M., Hoebers F.J.P., et al. Effectiveness of salvage selective and modified radical neck dissection for regional pathologic lymphadenopathy after chemoradiation. Head Neck 2009, 31:593-603.
41. Goerres G.W., Haenggeli C.A., Allaoua M., Albrecht S.R., Dulguerov P., Becker M., et al. Direct comparison of F-18-FDG PET and ultrasound in the follow-up of patients with squamous cell cancer of the head and neck. Nuklearmedizin 2000, 39:246-250.
42. Clavel S., Charron M.P., Bélair M., Delouya G., Fortin B., Després P., et al. The role of computed tomography in the management of the neck after chemoradiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 2012, 82:567-573.
43. Isles M.G., McConkey C., Mehanna H.M. A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol 2008, 33:210-222.
44. Schoeder H., Fury M., Lee N., Kraus D. PET monitoring of therapy response in head and neck squamous cell carcinoma. J Nucl Med 2009, 50:S74-S88.
45. Higashi K., Clavo A.C., Wahl R.L. Does FDG uptake measure proliferative activity of human cancer cell? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med 1993, 34:414-419.
46. Nayak J.V., Walvekar R.R., Andrade R.S., Daamen N., Lai S.Y., Argiris A., et al. Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT. Laryngoscope 2007, 117:2129-2134.
47. UK Clinical Research Network [site Internet]. Available on: (accessed on 03 September 2012). http://public.ukcrn.org.uk/search/StudyDetail.aspx%3FStudyID=3799.
48. Kuntz A.L., Weymuller E.A. Impact of neck dissection on quality of life. Laryngoscope 1999, 109:1334-1338.
49. Doweck I., Robbins K.T., Mendenhall W.M., Hinerman R.W., Morris C., Amdur R. Neck level-specific nodal metastases in oropharyngeal cancer: is there a role for selective neck dissection after definitive radiation therapy. Head Neck 2003, 25:960-967.
50. Mukhija V., Gupta S., Jacobson A.S., Eloy J.A., Genden E.M. Selective neck dissection following adjuvant therapy for advanced head and neck cancer. Head neck 2009, 31:183-188.
51. Hehr T., Classen J., Schreck U., Glocker S., Koitschev A., Bamberg M., et al. Selective lymph node dissection following hyperfractionated accelerated radio-(chemo)therapy for advanced head and neck cancer. Strahlenther Onkol 2002, 178:363-368.
52. Hillel A.T., Fakhry C.F., Pai S.I., Williams M.F., Blanco R.G.F., Zinreich E.S., et al. Selective versus comprehensive neck dissection after chemoradiation for advanced oropharyngeal squamous cell carcinoma. Otolaryngol Head Neck Surg 2009, 141:737-742.
53. Yeung A.R., Liauw S.L., Amdur R., Manusco A.A., Hinerman R.W., Morris C.G., et al. Lymph node-positive head and neck cancer treated with definitive radiotherapy. Cancer 2008, 112:1076-1082.
54. Robbins K.T., Dhiwakar M., Vieira F., Rao K., Malone J. Efficacy of super-selective neck dissection following chemoradiation for advanced head and neck cancer. Oral Oncol 2012, 48:1185-1189.
55. Mendenhall W.M., Villaret D.B., Amdur R.J., Hinerman R.W., Mancusco A.A. Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck Head Neck 2002, 24:1012-1018.